Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-19-012212
Filing Date
2019-08-13
Accepted
2019-08-13 16:16:38
Documents
81
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 24349
2 ex99-1.htm EX-99.1 599367
3 ex99-2.htm EX-99.2 314130
4 ex99-2_001.jpg GRAPHIC 14150
5 ex99-3.htm EX-99.3 16645
6 ex99-4.htm EX-99.4 15555
  Complete submission text file 0001493152-19-012212.txt   4591421

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE aezs-20190630.xml EX-101.INS 844299
8 XBRL SCHEMA FILE aezs-20190630.xsd EX-101.SCH 61426
9 XBRL CALCULATION FILE aezs-20190630_cal.xml EX-101.CAL 84631
10 XBRL DEFINITION FILE aezs-20190630_def.xml EX-101.DEF 196651
11 XBRL LABEL FILE aezs-20190630_lab.xml EX-101.LAB 363896
12 XBRL PRESENTATION FILE aezs-20190630_pre.xml EX-101.PRE 285686
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 191020817
SIC: 2834 Pharmaceutical Preparations